why choose us

First received: March 14, 2023

Clinical Trial: The Impact of AMPA Receptor Blockade on Ketamine's Anti-Suicidal Effects

Study Status: Completed

Recruit Status: RECRUITING

Condition: Depressive Disorder

Study Type: INTERVENTIONAL


Official Title: The Impact of AMPA Receptor Blockade on Ketamine's Anti-Suicidal Effects

Brief Summary: The purpose of this study is to test the hypothesis that the anti-depressant and anti-suicidal effects of the N-methyl-D-aspartate receptor (NMDAR) antagonist Ketamine is critically dependent on stimulation of Alpha-Amino-3-Hydroxy-5-Methyl-4-Isoxazole Propionic Acid receptors (AMPAR).

Read more